바이오센서 시장 : 점유율, 규모, 동향, 산업 분석 보고서-용도별, 최종 용도별, 지역별-시장 예측(2025-2034년)

Biosensors Market Share, Size, Trends, Industry Analysis Report, By Application (Medical, Food Toxicity, Bioreactor, Agriculture, Environment, and Consumer Electronics); By End-Use; By Region; Segment Forecast, 2025 - 2034

US $ 4,250 ￦ 5,908,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,250 ￦ 7,299,000

PDF (Multi User License)

PDF 보고서를 동일 기업 20명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,250 ￦ 8,689,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

Polaris Market Research의 최근 조사에 따르면 세계의 바이오센서 시장 규모는 2034년까지 582억 6,869만 달러에 이를 것으로 예상됩니다. 이 설문조사 보고서는 현재 시장 역학을 자세히 파악하고 향후 시장 성장에 대한 분석을 제공합니다.

바이오센서 시장은 현저한 기술적 진보에 의해 크게 뒷받침되어 현저한 성장을 이루고 있습니다. 이러한 발전은 헬스케어부터 환경 모니터링에 이르기까지 다양한 산업에 걸친 바이오센서의 혁신과 채용의 궤도를 형성하는데 있어서 매우 중요한 역할을 하고 있습니다. 이 약진의 중심에는 나노기술, 마이크로플루이딕스공학, 인공지능, 생명공학 등 여러 첨단기술의 융합이 있습니다. 이러한 시너지 효과는 고감도, 고정밀, 비용 효율적인 바이오센서의 개발을 가능하게 하고, 진단, 포인트 오브 케어 검사, 실시간 모니터링 용도의 상황에 혁명을 가져오고 있습니다.

바이오센서 시장의 성장의 주요 원동력 중 하나는 소형화와 집적화의 무자비한 추구입니다. 소형화에 의해 휴대형이나 장착형의 바이오센서의 개발이 가능하게 되어, 개인이 자신의 건강을 실시간으로 모니터할 수 있게 되어, 헬스케어 전문가가 개인에 맞는 치료를 제공할 수 있게 됩니다. 게다가, 여러 센싱 모달리티와 기능을 단일 플랫폼에 통합하면 다양성과 유용성이 향상되어 기존의 진단 용도를 넘어 바이오센서의 범위가 확대됩니다. 예를 들어, 무선 통신 기능과 통합된 바이오센서는 환자의 원격 모니터링을 용이하게 하고, 원격 의료를 강화하며, 특히 의료가 없는 지역에서 건강 관리에 대한 접근을 개선합니다.

고급 신호 처리 알고리즘과 인공지능(AI) 기능을 갖춘 스마트 바이오센서의 등장도 시장 성장을 뒷받침하는 원동력이 되고 있습니다. 이러한 스마트 바이오센서는 복잡한 생체 신호를 실시간으로 분석하고 의미 있는 인사이트를 추출하며 최종 사용자에게 실용적인 정보를 제공할 수 있습니다. 머신러닝 알고리즘은 변화하는 환경 조건과 사용자 선호도에 적응함으로써 센서 성능의 지속적인 개선을 가능하게 하여 신뢰성과 정확성을 향상시킵니다. 또한 바이오센서 플랫폼에 AI 주도 분석을 통합함으로써 정밀의료부터 환경 감시까지 다양한 영역에서 데이터 주도 의사결정을 용이하게 하고, 혁신을 촉진하고 시장 확대를 촉진합니다.

바이오 센서 시장 보고서 하이라이트

용도별로 의료 분야는 2023년 시장을 독점했습니다. 의료진단에서 바이오센서는 콜레스테롤 검사, 혈당 모니터링, 임신검사, 감염증의 식별 등에 이용되고 있습니다.

최종 용도별로 POC 검사는 바이오 센서 시장의 주요 점유율을 차지합니다. 의료 진단 시장은 기존의 실험실 기반 검사에서 포인트 오브 케어 검사(POCT)로의 전환이 진행되고 있습니다.

북미의 바이오센서 시장은 2023년에 큰 성장을 이루었습니다. 북미의 바이오센서 시장은 특히 생명공학과 헬스케어 혁신에서 연구개발에 대한 왕성한 투자로부터 혜택을 누리고 있습니다.

목차

제1장 서론

• 보고서 설명
  • 연구의 목적
  • 시장 범위
  • 가정
• 이해관계자

제2장 조사 방법

• 조사 방법
• 조사 범위 및 전제
• 정보 조달
  • 구입한 데이터베이스
  • 내부 데이터베이스
  • 2차 정보
  • 제3자의 시점
  • 1차 조사
• 정보 분석
  • 데이터 분석 모델
• 시장의 형성과 데이터의 시각화
• 데이터 검증 및 공개(2차 정보)

제3장 주요 요약

제4장 시장 인사이트

• 바이오센서 : 업계 개요
• 밸류체인 분석
  • 바이오센서 시장 역학
  • 성장 촉진요인 및 기회
    • 다양한 분야에서 POC(Point of Care) 진단 수요 증가
    • 기술의 진보
  • 억제요인 및 과제
    • 엄격한 규제 환경
• 포터의 5개의 힘
  • 대체품의 위협 : 낮음
  • 신규 참가업체의 위협 : 중간
  • 구매자의 협상력 : 중간
  • 공급기업의 협상력 : 중간
  • 경쟁기업 간의 적대관계 : 고
• PESTLE 분석
• COVID-19의 영향 분석 및 업계 동향

제5장 바이오센서 시장 평가 : 용도별

• 서문
• 의료
  • 콜레스테롤
  • 혈당
  • 혈액가스 분석 장치
  • 임신 검사
  • 감염 검사
• 식품독성
• 바이오리액터
• 농업
• 환경
• 가전

제6장 바이오센서 시장 평가 : 최종 용도별

• 서문
• 재택 건강 관리 진단
• POC 테스트
• 식품산업
• 연구실
• 보안 및 바이오디펜스

제7장 바이오센서 시장 평가 : 지역별

• 서문
• 북미
• 미국
• 캐나다
• 유럽
• 프랑스
• 독일
• 영국
• 이탈리아
• 네덜란드
• 스페인
• 러시아
• 기타 유럽
• 아시아태평양
• 일본
• 중국
• 인도
• 말레이시아
• 인도네시아
• 한국
• 아시아태평양의 기타 국가
• 라틴아메리카
• 멕시코
• 브라질
• 아르헨티나
• 기타 라틴아메리카
• 중동 및 아프리카
• 사우디아라비아
• 아랍에미리트(UAE)
• 이스라엘
• 남아프리카
• 기타 중동 및 아프리카

제8장 경쟁 구도

• 주요 시장 기업 : 분류
• 전략적 틀
• 벤더 상황
• 전략의 분류
  • 제품 출시 및 확장
  • 파트너십, 협업 및 인수

제9장 기업 프로파일

• Koninklijke Philips NV
• Abbott Laboratories
• Net Sales by Market Segment
• Net Sales by Region
• Products and Services
• DuPont
• Medtronic
• Revenue by Market Segment
• Revenue by Region
• Nova Biomedical
• Siemens
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories, Inc.
• Zimmer & Peacock AS
• TDK Corporation

AJY

영문 목차

영문목차

The global biosensors market size is expected to reach USD 58,268.69 million by 2034, according to a new study by Polaris Market Research. The report "Biosensors Market Share, Size, Trends, Industry Analysis Report, By Application (Medical, Food Toxicity, Bioreactor, Agriculture, Environment, and Consumer Electronics); By End-Use; By Region; Segment Forecast, 2025 - 2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The biosensor market is experiencing remarkable growth, largely propelled by significant technological advancements. These advancements play a pivotal role in shaping the trajectory of biosensor innovation and adoption across various industries, ranging from healthcare to environmental monitoring and beyond. At the heart of this surge lies the convergence of multiple cutting-edge technologies, including nanotechnology, microfluidics, artificial intelligence, and biotechnology. These synergies have enabled the development of highly sensitive, accurate, and cost-effective biosensors, revolutionizing the landscape of diagnostics, point-of-care testing, and real-time monitoring applications.

One of the primary driving factors behind the growth of the biosensor market is the relentless pursuit of miniaturization and integration. Miniaturization allows for the development of portable and wearable biosensors, empowering individuals to monitor their health in real-time and enabling healthcare professionals to deliver personalized treatments. Moreover, the integration of multiple sensing modalities and functionalities into a single platform enhances versatility and utility, expanding the scope of biosensors beyond traditional diagnostic applications. For instance, biosensors integrated with wireless communication capabilities facilitate remote monitoring of patients, empowering telemedicine and improving healthcare accessibility, particularly in underserved regions.

The advent of smart biosensors equipped with advanced signal processing algorithms and artificial intelligence (AI) capabilities is another driving force propelling market growth. These smart biosensors can analyze complex biological signals in real-time, extract meaningful insights, and provide actionable information to end-users. Machine learning algorithms enable continuous improvement in sensor performance by adapting to changing environmental conditions and user preferences, thereby enhancing reliability and accuracy. Additionally, the integration of AI-driven analytics into biosensor platforms facilitates data-driven decision-making in various domains, from precision medicine to environmental surveillance, fostering innovation and driving market expansion.

Biosensors Market Report Highlights

On the basis of application, the medical segment dominated the market in 2023. In medical diagnostics, biosensors are utilized for cholesterol testing, blood glucose monitoring, pregnancy testing, and the identification of infectious disorders.

Based on end-use, POC testing accounted for the major share of the biosensors market. The medical diagnostics market is experiencing a shift from traditional laboratory-based testing to point-of-care testing (POCT)

The Biosensors Market in North America experienced significant growth in 2023. The North America biosensor market has benefited from robust investments in research and development, particularly in biotechnology and healthcare innovation.

The global key market players include Koninklijke Philips N.V., Abbott Laboratories, DuPont, Medtronic, Siemens, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., and TDK Corporation.

Polaris Market Research has segmented the Biosensors Market report based on application, end-use, and region:

Biosensors, Application Outlook (Revenue - USD Million, 2020-2034)

• Medical
• Cholesterol
• Blood Glucose
• Blood Gas Analyzer
• Pregnancy Testing
• Infectious Testing
• Food Toxicity
• Bioreactor
• Agriculture
• Environment
• Consumer Electronics

Biosensors, End-Use Outlook (Revenue - USD Million, 2020-2034)

• Home Healthcare Diagnostics
• POC Testing
• Food Industry
• Research Laboratories
• Security and Biodefense

Biosensors, Regional Outlook (Revenue - USD Million, 2020-2034)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Malaysia
• Australia
• Rest of APAC
• Latin America
• Argentina
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
• UAE
• Saudi Arabia
• Israel
• South Africa
• Rest of MEA

Table of Contents

Chapter 1. Introduction

• 1.1 Report Description
  • 1.1.1 Objective of the Study
  • 1.1.2 Market Scope
  • 1.1.3 Assumptions
• 1.2 Stakeholders

Chapter 2. Research Methodology

• 2.1 Research Methodology
• 2.2 Research Scope and Assumptions
• 2.3 Information Procurement
  • 2.3.1 Purchased Database
  • 2.3.2 Internal Database
  • 2.3.3 Secondary Sources
  • 2.3.4 Third Party Perspective
  • 2.3.5 Primary Research
• 2.4 Information Analysis
  • 2.4.1 Data Analysis Models
• 2.5 Market Formulation and Data Visualization
• 2.6 Data Validation and Publishing (Secondary Sources)

Chapter 3. Executive Summary

Chapter 4. Market Insights

• 4.1 Biosensors - Industry snapshot
• 4.2 Biosensors Market - Value Chain Analysis
  • 4.2.1 Biosensors Market Dynamics
  • 4.2.2 Drivers and Opportunities
    • 4.2.2.1 Rising demand for point-of-care diagnostics across various sectors
    • 4.2.2.2 Technological Advancement
  • 4.2.3 Restraints and Challenges
    • 4.2.3.1 Stringent regulatory environment
• 4.3 Biosensors Market - Porter's Five Forces
  • 4.3.1 Threat of Substitutes: (Low)
  • 4.3.2 Threat of New Entrants: (Moderate)
  • 4.3.3 Bargaining power of buyers: (Moderate)
  • 4.3.4 Bargaining power of suppliers: (Moderate)
  • 4.3.5 Competitive Rivalry: (High)
• 4.4 Biosensors Market - PESTLE Analysis
• 4.5 Covid-19 Impact Analysis & Industry Trends

Chapter 5. Biosensors Market Assessment by Application

• 5.1 Introduction
• 5.2 Medical
  • 5.2.1 Cholesterol
  • 5.2.2 Blood Glucose
  • 5.2.3 Blood Gas Analyzer
  • 5.2.4 Pregnancy Testing
  • 5.2.5 Infectious Testing
• 5.3 Food Toxicity
• 5.4 Bioreactor
• 5.5 Agriculture
• 5.6 Environment
• 5.7 Consumer Electronics

Chapter 6. Biosensors Market Assessment by End-Use

• 6.1 Introduction
• 6.2 Home Healthcare Diagnostics
• 6.3 POC Testing
• 6.4 Food Industry
• 6.5 Research Laboratories
• 6.6 Security and Biodefense

Chapter 7. Biosensors Market Assessment by Region

• 7.1 Introduction
• 7.2 Biosensors Market - North America
  • 7.2.1 North America Biosensors, By Application
    • 7.2.1.1 North America Biosensors, By Medical
  • 7.2.2 North America Biosensors, By End-Use
  • 7.2.3 Biosensors Market - U.S.
    • 7.2.3.1 U.S. Biosensors, By Application
    • 7.2.3.1.1 U.S. Biosensors, By Medical
    • 7.2.3.2 U.S. Biosensors, By End-Use
  • 7.2.4 Biosensors Market - Canada
    • 7.2.4.1 Canada Biosensors, By Application
    • 7.2.4.1.1 Canada Biosensors, By Medical
    • 7.2.4.2 Canada Biosensors, By End-Use
• 7.3 Biosensors Market - Europe
  • 7.3.1 Europe Biosensors, By Application
    • 7.3.1.1 Europe Biosensors, By Medical
  • 7.3.2 Europe Biosensors, By End-Use
  • 7.3.3 Biosensors Market - France
    • 7.3.3.1 France Biosensors, By Application
    • 7.3.3.1.1 France Biosensors, By Medical
    • 7.3.3.2 France Biosensors, By End-Use
  • 7.3.4 Biosensors Market - Germany
    • 7.3.4.1 Germany Biosensors, By Application
    • 7.3.4.1.1 Germany Biosensors, By Medical
    • 7.3.4.2 Germany Biosensors, By End-Use
  • 7.3.5 Biosensors Market - UK
    • 7.3.5.1 UK Biosensors, By Application
    • 7.3.5.1.1 UK Biosensors, By Medical
    • 7.3.5.2 UK Biosensors, By End-Use
  • 7.3.6 Biosensors Market - Italy
    • 7.3.6.1 Italy Biosensors, By Application
    • 7.3.6.1.1 Italy Biosensors, By Medical
    • 7.3.6.2 Italy Biosensors, By End-Use
  • 7.3.7 Biosensors Market - Netherlands
    • 7.3.7.1 Netherlands Biosensors, By Application
    • 7.3.7.1.1 Netherlands Biosensors, By Medical
    • 7.3.7.2 Netherlands Biosensors, By End-Use
  • 7.3.8 Biosensors Market - Spain
    • 7.3.8.1 Spain Biosensors, By Application
    • 7.3.8.1.1 Spain Biosensors, By Medical
    • 7.3.8.2 Spain Biosensors, By End-Use
  • 7.3.9 Biosensors Market - Russia
    • 7.3.9.1 Russia Biosensors, By Application
    • 7.3.9.1.1 Russia Biosensors, By Medical
    • 7.3.9.2 Russia Biosensors, By End-Use
  • 7.3.10 Biosensors Market - Rest of Europe
    • 7.3.10.1 Rest of Europe Biosensors, By Application
    • 7.3.10.1.1 Rest of Europe Biosensors, By Medical
    • 7.3.10.2 Rest of Europe Biosensors, By End-Use
• 7.4 Biosensors Market - Asia Pacific
  • 7.4.1 Asia Pacific Biosensors, By Application
    • 7.4.1.1 Asia Pacific Biosensors, By Medical
  • 7.4.2 Asia Pacific Biosensors, By End-Use
  • 7.4.3 Biosensors Market - Japan
    • 7.4.3.1 Japan Biosensors, By Application
    • 7.4.3.1.1 Japan Biosensors, By Medical
    • 7.4.3.2 Japan Biosensors, By End-Use
  • 7.4.4 Biosensors Market - China
    • 7.4.4.1 China Biosensors, By Application
    • 7.4.4.1.1 China Biosensors, By Medical
    • 7.4.4.2 China Biosensors, By End-Use
  • 7.4.5 Biosensors Market - India
    • 7.4.5.1 India Biosensors, By Application
    • 7.4.5.1.1 India Biosensors, By Medical
    • 7.4.5.2 India Biosensors, By End-Use
  • 7.4.6 Biosensors Market - Malaysia
    • 7.4.6.1 Malaysia Biosensors, By Application
    • 7.4.6.1.1 Malaysia Biosensors, By Medical
    • 7.4.6.2 Malaysia Biosensors, By End-Use
  • 7.4.7 Biosensors Market - Indonesia
    • 7.4.7.1 Indonesia Biosensors, By Application
    • 7.4.7.1.1 Indonesia Biosensors, By Medical
    • 7.4.7.2 Indonesia Biosensors, By End-Use
  • 7.4.8 Biosensors Market - South Korea
    • 7.4.8.1 South Korea Biosensors, By Application
    • 7.4.8.1.1 South Korea Biosensors, By Medical
    • 7.4.8.2 South Korea Biosensors, By End-Use
  • 7.4.9 Biosensors Market - Rest of APAC
    • 7.4.9.1 Rest of APAC Biosensors, By Application
    • 7.4.9.1.1 Rest of APAC Biosensors, By Medical
    • 7.4.9.2 Rest of APAC Biosensors, By End-Use
• 7.5 Biosensors Market - Latin America
  • 7.5.1 Latin America Biosensors, By Application
    • 7.5.1.1 Latin America Biosensors, By Medical
  • 7.5.2 Latin America Biosensors, By End-Use
  • 7.5.3 Biosensors Market - Mexico
    • 7.5.3.1 Mexico Biosensors, By Application
    • 7.5.3.1.1 Mexico Biosensors, By Medical
    • 7.5.3.2 Mexico Biosensors, By End-Use
  • 7.5.4 Biosensors Market - Brazil
    • 7.5.4.1 Brazil Biosensors, By Application
    • 7.5.4.1.1 Brazil Biosensors, By Medical
    • 7.5.4.2 Brazil Biosensors, By End-Use
  • 7.5.5 Biosensors Market - Argentina
    • 7.5.5.1 Argentina Biosensors, By Application
    • 7.5.5.1.1 Argentina Biosensors, By Medical
    • 7.5.5.2 Argentina Biosensors, By End-Use
  • 7.5.6 Biosensors Market - Rest of Latin America
    • 7.5.6.1 Rest of Latin America Biosensors, By Application
    • 7.5.6.1.1 Rest of Latin America Biosensors, By Medical
    • 7.5.6.2 Rest of Latin America Biosensors, By End-Use
• 7.6 Biosensors Market - Middle East Africa
  • 7.6.1 Middle East Africa Biosensors, By Application
    • 7.6.1.1 Middle East Africa Biosensors, By Medical
  • 7.6.2 Middle East Africa Biosensors, By End-Use
  • 7.6.3 Biosensors Market - Saudi Arabia
    • 7.6.3.1 Saudi Arabia Biosensors, By Application
    • 7.6.3.1.1 Saudi Arabia Biosensors, By Medical
    • 7.6.3.2 Saudi Arabia Biosensors, By End-Use
  • 7.6.4 Biosensors Market - UAE
    • 7.6.4.1 UAE Biosensors, By Application
    • 7.6.4.1.1 UAE Biosensors, By Medical
    • 7.6.4.2 UAE Biosensors, By End-Use
  • 7.6.5 Biosensors Market - Israel
    • 7.6.5.1 Israel Biosensors, By Application
    • 7.6.5.1.1 Israel Biosensors, By Medical
    • 7.6.5.2 Israel Biosensors, By End-Use
  • 7.6.6 Biosensors Market - South Africa
    • 7.6.6.1 South Africa Biosensors, By Application
    • 7.6.6.1.1 South Africa Biosensors, By Medical
    • 7.6.6.2 South Africa Biosensors, By End-Use
  • 7.6.7 Biosensors Market - Rest of MEA
    • 7.6.7.1 Rest of MEA Biosensors, By Application
    • 7.6.7.1.1 Rest of MEA Biosensors, By Medical
    • 7.6.7.2 Rest of MEA Biosensors, By End-Use

Chapter 8. Competitive Landscape

• 8.1 Key Market Players: Categorization
• 8.2 Strategy Framework
• 8.3 Vendor Landscape
• 8.4 Strategies Categorization
  • 8.4.1 Product Launch/Expansion
  • 8.4.2 Partnership/Collaboration/Acquisition

Chapter 9. Company Profiles

• 9.1 Koninklijke Philips N.V.
  • 9.1.1 Business Overview
  • 9.1.2 Financial Snapshot
    • 9.1.2.1 Sales by Market Segment
    • 9.1.2.2 Sales by Region
  • 9.1.3 Products Benchmarking
  • 9.1.4 Recent Developments
• 9.2 Abbott Laboratories
  • 9.2.1 Business Overview
  • 9.2.2 Financial Snapshot
    • 9.2.2.1 Net Sales by Market Segment
    • 9.2.2.2 Net Sales by Region
  • 9.2.3 Products and Services
• 9.3 DuPont
  • 9.3.1 Business Overview
  • 9.3.2 Financial Snapshot
    • 9.3.2.1 Net Sales by Region
  • 9.3.3 Products and Services
  • 9.3.4 Recent Developments
• 9.4 Medtronic
  • 9.4.1 Business Overview
  • 9.4.2 Financial Snapshot
    • 9.4.2.1 Revenue by Market Segment
    • 9.4.2.2 Revenue by Region
  • 9.4.3 Products Benchmarking
  • 9.4.4 Recent Developments
• 9.5 Nova Biomedical
  • 9.5.1 Business Overview
  • 9.5.2 Products Benchmarking
  • 9.5.3 Recent Developments
• 9.6 Siemens
  • 9.6.1 Business Overview
  • 9.6.2 Financial Snapshot
    • 9.6.2.1 Revenue by Region
  • 9.6.3 Products and Services
  • 9.6.4 Recent Developments
• 9.7 Thermo Fisher Scientific Inc.
  • 9.7.1 Business Overview
  • 9.7.2 Financial Snapshot
    • 9.7.2.1 Revenue by Market Segment
    • 9.7.2.2 Revenue by Region
  • 9.7.3 Products Benchmarking
  • 9.7.4 Recent Developments
• 9.8 Bio-Rad Laboratories, Inc.
  • 9.8.1 Business Overview
  • 9.8.2 Financial Snapshot
    • 9.8.2.1 Net Sales by Region
  • 9.8.3 Products and Services
  • 9.8.4 Recent Developments
• 9.9 Zimmer & Peacock AS
  • 9.9.1 Business Overview
  • 9.9.2 Products and Services
  • 9.9.3 Recent Developments
• 9.10 TDK Corporation
  • 9.10.1 Business Overview
  • 9.10.2 Financial Snapshot
    • 9.10.2.1 Net Sales by Region
    • 9.10.2.2 Net Sales by Region
  • 9.10.3 Products and Services
  • 9.10.4 Recent Developments

관련자료